2020/4/3  
Vice president discusses timeline for COVID-19 R&D (2020/03/26)
其它新聞 Other News   
  • Taiwan confirms 17 more COVID-19 cases for total of 252
  • People in 20s have Taiwan’s highest infection rate: COVID-19 case data
  • Two China Airlines flights to repatriate Taiwanese stranded in China’s Hubei
  • US warship transits Taiwan Strait
  • Pickup period starts for online mask orders
  • Local borough wardens overwhelmed with work taking care of self-isolators
  • Discounts for mobile payment to launch as early as April
  • COVID-19: How to distinguish between truth and disinformation
  • Tea contains substance that could inhibit coronavirus: research
  • Government issues advisory for cinemas, including denying feverish patrons entry
  • 英文 English 
    Vice president discusses timeline for COVID-19 R&D (2020/03/26)

    At research labs around the world, the race is on to produce a cure and vaccine for COVID-19. Vice President Chen Chien-jen says Taiwan is working on a vaccine, but that it will be at least a year before it clears clinical trials. He says a potential treatment could be ready for mass production within six months. Taiwan researchers are also developing a screening test that gets results in just 15 minutes. Vice President Chen says the government wants the test ready for market in three months.

    Two red lines appear on the paper strip, indicating a positive for COVID-19. This quick test was developed by Academia Sinica. Vice President Chen said he wanted the tool to hit the market quickly.

    Chen Chien-jen
    Vice president
    As they say, “What if. What if the disease entered the community and all the patients rushed to the open health centers?” At such a time, we would need rapid diagnostic tests. So I hope these rapid diagnostic tests will be ready in the coming two to three months.

    Huang Li-min
    Infectious Diseases Society of Taiwan
    Domestically, the biggest obstacle is clinical trials. There are not enough subjects with the disease, so domestic testing and verification are difficult. That’s a hurdle in the process. If you’re able to bring in patient samples from overseas, then it’s more doable. You’d be able to bring it to market faster.

    Prevention is better than cure. Around the world, countries including Taiwan are racing to produce a vaccine.

    Chen Chien-jen
    Vice president
    Vaccines are administered on healthy people, so they are held to stricter standards.
    Currently they are still in the animal testing phase. I think that it will be another year or one and a half years before a vaccine is ready.

    Turning to COVID-19 treatments. Chen said the goal was for an anti-viral drug to enter mass production, just in time to treat patients who test positive in the new quick tests. He said that given the current state of drug development, Taiwan should be able to mass produce with half a year.

    中文 Chinese  
    陳建仁:武漢肺炎快篩劑 有望三個月內量產

    世界多國都在研發抗病毒藥物和疫苗,而中研院,也開發出了能在15分鐘驗出結果的快篩試劑,讓副總統陳建仁希望,能在三個月內達到量產。此外,抗病毒藥物,像是瑞德西韋,陳建仁信心喊話,半年內有望問世,但也坦言,基於安全,疫苗可能還是要等一年到一年半。

    試紙上 ,顯示兩條線,是中研院的快篩試劑,抓到武肺病毒最佳證明。副總統陳建仁期望這款利器,加速問世。

    [[副總統 陳建仁]]
    “萬一進入到了社區,所有的病人都跑到開業醫那裡,怎麼辦?那時候就需要快篩了,所以快篩大概2到3個月,大概3個月內希望他能夠完成。”

    [[台灣感染症醫學會理事長 黃立民]]
    “國內最大問題就是國內的臨床,陽性檢體太少,所以可能光是在國內做驗證,會有困難,這個會卡到進程。如果你能夠拿到國外病人的檢體,就比較可以、比較快的發展出來。”

    預防勝於治療,疫苗的開發進度,各界同樣望穿秋水。

    [[副總統 陳建仁]]
    “這個疫苗是健康的人要打,所以它的要求會更嚴格,而且現在還在動物實驗的階段,我相信大概未來的一年,或者一年半才會有。”

    至於臨床藥物,陳建仁說,他期待的抗病毒藥物,是未來快篩結果出來後,就可以馬上使用的藥。目前武漢肺炎抗病毒藥物,他認為半年內可以問世。
    關於民視 常見問題 如何收看民視 意見信箱

    © 2009 FTV All Rights Reserved 版權所有‧盜用必究 Designed by FTV
    地址:244 新北市林口區信義路99號   觀服電話:(02)8601-8601 服務時間:週一至週日09:00-21:00   傳真:(02)8601-3955

    本網站使用 cookie 與其他技術為您提供更好的使用體驗, 請閱讀我們的的隱私權政策,通過使用我們的網站,表示您確認並同意我們的政策。